342 related articles for article (PubMed ID: 7964467)
21. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells.
Subramanyam M; McLellan B; Labrecque N; Sekaly RP; Huber BT
J Immunol; 1993 Sep; 151(5):2538-45. PubMed ID: 8395548
[TBL] [Abstract][Full Text] [Related]
22. The V beta complementarity determining region 1 of a major histocompatibility complex (MHC) class I-restricted T cell receptor is involved in the recognition of peptide/MHC I and superantigen/MHC II complex.
Bellio M; Lone YC; de la Calle-Martin O; Malissen B; Abastado JP; Kourilsky P
J Exp Med; 1994 Apr; 179(4):1087-97. PubMed ID: 8145032
[TBL] [Abstract][Full Text] [Related]
23. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
24. Selective binding of bacterial toxins to major histocompatibility complex class II-expressing cells is controlled by invariant chain and HLA-DM.
Lavoie PM; Thibodeau J; Cloutier I; Busch R; Sékaly RP
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6892-7. PubMed ID: 9192662
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of a T-cell receptor beta-chain complexed with a superantigen.
Fields BA; Malchiodi EL; Li H; Ysern X; Stauffacher CV; Schlievert PM; Karjalainen K; Mariuzza RA
Nature; 1996 Nov; 384(6605):188-92. PubMed ID: 8906797
[TBL] [Abstract][Full Text] [Related]
26. Major histocompatibility complex independent clonal T cell anergy by direct interaction of Staphylococcus aureus enterotoxin B with the T cell antigen receptor.
Hewitt CR; Lamb JR; Hayball J; Hill M; Owen MJ; O'Hehir RE
J Exp Med; 1992 Jun; 175(6):1493-9. PubMed ID: 1588277
[TBL] [Abstract][Full Text] [Related]
27. V alpha domain modulates the multiple topologies of mouse T cell receptor V beta20/staphylococcal enterotoxins A and E complexes.
Bravo de Alba Y; Marche PN; Cazenave PA; Cloutier I; Sekaly RP; Thibodeau J
Eur J Immunol; 1997 Jan; 27(1):92-9. PubMed ID: 9022003
[TBL] [Abstract][Full Text] [Related]
28. MHC-specific recognition of a bacterial superantigen by weakly reactive T cells.
Surman S; Deckhut AM; Blackman MA; Woodland DL
J Immunol; 1994 May; 152(10):4893-902. PubMed ID: 8176210
[TBL] [Abstract][Full Text] [Related]
29. Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2.
Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI
Eur J Immunol; 1995 Dec; 25(12):3437-44. PubMed ID: 8566035
[TBL] [Abstract][Full Text] [Related]
30. MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.
Shaler CR; Choi J; Rudak PT; Memarnejadian A; Szabo PA; Tun-Abraham ME; Rossjohn J; Corbett AJ; McCluskey J; McCormick JK; Lantz O; Hernandez-Alejandro R; Haeryfar SMM
PLoS Biol; 2017 Jun; 15(6):e2001930. PubMed ID: 28632753
[TBL] [Abstract][Full Text] [Related]
31. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
32. Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro.
Seth A; Stern LJ; Ottenhoff TH; Engel I; Owen MJ; Lamb JR; Klausner RD; Wiley DC
Nature; 1994 May; 369(6478):324-7. PubMed ID: 8183371
[TBL] [Abstract][Full Text] [Related]
33. Binding of natural variants of staphylococcal superantigens SEG and SEI to TCR and MHC class II molecule.
Fernández MM; De Marzi MC; Berguer P; Burzyn D; Langley RJ; Piazzon I; Mariuzza RA; Malchiodi EL
Mol Immunol; 2006 Mar; 43(7):927-38. PubMed ID: 16023209
[TBL] [Abstract][Full Text] [Related]
34. Interplay between superantigens and immunoreceptors.
Petersson K; Forsberg G; Walse B
Scand J Immunol; 2004 Apr; 59(4):345-55. PubMed ID: 15049778
[TBL] [Abstract][Full Text] [Related]
35. MHC class II-dependent activation of CD4+ T cell hybridomas by human mast cells through superantigen presentation.
Poncet P; Arock M; David B
J Leukoc Biol; 1999 Jul; 66(1):105-12. PubMed ID: 10410997
[TBL] [Abstract][Full Text] [Related]
36. Enterotoxin residues determining T-cell receptor V beta binding specificity.
Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
[TBL] [Abstract][Full Text] [Related]
37. Identification of class II major histocompatibility complex and T cell receptor binding sites in the superantigen toxic shock syndrome toxin 1.
Hurley JM; Shimonkevitz R; Hanagan A; Enney K; Boen E; Malmstrom S; Kotzin BL; Matsumura M
J Exp Med; 1995 Jun; 181(6):2229-35. PubMed ID: 7760008
[TBL] [Abstract][Full Text] [Related]
38. T cell receptor interaction with peptide/major histocompatibility complex (MHC) and superantigen/MHC ligands is dominated by antigen.
Ehrich EW; Devaux B; Rock EP; Jorgensen JL; Davis MM; Chien YH
J Exp Med; 1993 Aug; 178(2):713-22. PubMed ID: 8393480
[TBL] [Abstract][Full Text] [Related]
39. H2-O inhibits presentation of bacterial superantigens, but not endogenous self antigens.
Qi L; Ostrand-Rosenberg S
J Immunol; 2001 Aug; 167(3):1371-8. PubMed ID: 11466355
[TBL] [Abstract][Full Text] [Related]
40. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.
Spertini F; Spits H; Geha RS
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
